Letters Overtreatment

Response to Whitehead

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7088 (Published 24 October 2012) Cite this as: BMJ 2012;345:e7088
  1. David Colquhoun, research professor
  1. 1UCL, London WC1E 6BT, UK
  1. d.colquhoun{at}ucl.ac.uk

I guess one would expect the chief executive of the Association of the British Pharmaceutical Industry to respond by denying everything.1 2 But it is very condescending to …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe